2022 Speaker Faculty Meet the expert speakers uniting in Boston this June to provide you with the know-how to harness the power of TCRs Adrian Rawcliffe CEO Adaptimmune Cintia Piccina Chief Commercial Officer Adaptimmune Joanna Brewer Chief Scientific Officer Adaptimmune Piotr Pierog VP, Precision & Translational Medicine Affini-T Therapeutics Reagan Jarvis CEO Anocca Tom Soloway CEO T-knife Thearpeutics Dongxing Zha CTO, TCR Discovery & Engineering Alloy Therapeutics Gang Zeng President & CEO T-Cure Bioscience Inc. Sungeun Kim Principal Scientist, Oncology Research Amgen Cheng Liu Founder & CEO Eureka Therapeutics Katja Fink Senior Director, Discovery ImmunoScape Stefania Gobessi Director, Discovery Gadeta Franco Marincola SVP, Global Head of Research Kite Pharma Parameswaran Hari SVP, Clinical Science Iovance Biotherapeutics Stephen Megit VP, Business Development Immunocore Aaron Vernon VP, Manufacturing TCR2 Therapeutics Shannon Oda Assistant Professor Seattle Children’s Research Institute & University of Washington Thomas Andresen CEO T-Cypher Bio Cagan Gurer VP, Discovery TScan Therapeutics Peggy Sotiropoulou CSO T-knife Therapeutics Sadhak Sengupta Associate Director, Immunology Triumvira Immunologics James Clements Senior Director, Cell Therapy Immunology Athenex Michael Sheldon Senior Director, Scientific Affairs Sampled Thomas Holberg Blicher Senior Research Scientist Immudex Eduardo Davila Professor, Dept of Medicine University of Colorado Comprehensive Cancer Center Jens Eberlein Technical Lead, Immuno-Oncology LUMICKS Marvin Gee VP, Target Discovery & Co-Founder, 3T Biosciences 3T Biosciences VIEW WORKSHOPS VIEW AGENDA BACK TO TOP